These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3890933)

  • 1. An ultrastructural study of stored human platelets after washing using prostacyclin.
    Read NG; Radomski MW; Goodwin DA; Moncada S
    Br J Haematol; 1985 Jun; 60(2):305-14. PubMed ID: 3890933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and washing of human platelets with nitric oxide.
    Radomski MW; Palmer RM; Read NG; Moncada S
    Thromb Res; 1988 May; 50(4):537-46. PubMed ID: 2842884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin prolongs viability of washed human platelets.
    Blackwell GJ; Radomski M; Vargas JR; Moncada S
    Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates.
    Menitove JE; Frenzke M; Aster RH
    Transfusion; 1984; 24(6):528-31. PubMed ID: 6390814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENDOTHELIUM-DERIVED INHIBITORS EFFICIENTLY ATTENUATE THE AGGREGATION AND ADHESION RESPONSES OF REFRIGERATED PLATELETS.
    Reddoch KM; Montgomery RK; Rodriguez AC; Meledeo MA; Pidcoke HF; Ramasubramanian AK; Cap AP
    Shock; 2016 Feb; 45(2):220-7. PubMed ID: 26555740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined method for the preparation of washed human platelets using prostacyclin and gel filtration.
    Yamamoto K; Hirai A; Tamura Y; Yoshida S
    Thromb Res; 1988 Jun; 50(5):733-8. PubMed ID: 3046041
    [No Abstract]   [Full Text] [Related]  

  • 8. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
    Elias M; Heethuis A; Weggemans M; Bom V; Blom N; McShine RL; Halie MR; Smit Sibinga CT
    Ann Hematol; 1992 Jun; 64(6):292-8. PubMed ID: 1379080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation.
    Menter DG; Onoda JM; Moilanen D; Sloane BF; Taylor JD; Honn KV
    J Natl Cancer Inst; 1987 May; 78(5):961-9. PubMed ID: 3553692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P; Groscurth P; Varga G; Fischlein T; Fasol R
    Exp Hematol; 1987 Aug; 15(7):741-9. PubMed ID: 3301381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for washing of human platelets with prostacyclin.
    Radomski M; Moncada S
    Thromb Res; 1983 May; 30(4):383-9. PubMed ID: 6351341
    [No Abstract]   [Full Text] [Related]  

  • 12. Preservation of platelet function in cryopreserved platelet concentrates with prostacyclin.
    Johnson EJ; Mackie IJ; Machin SJ; Brozović B
    Clin Lab Haematol; 1984; 6(2):141-4. PubMed ID: 6207975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of N-(2-mercaptopropionyl)-glycine (MPG) for preparation and storage of platelets.
    Bergmann I; Siepmann T; Kleinert P; Pescarmona G; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):455-9. PubMed ID: 2465952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.
    Menter DG; Harkins C; Onoda J; Riorden W; Sloane BF; Taylor JD; Honn KV
    Invasion Metastasis; 1987; 7(2):109-28. PubMed ID: 3294727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostacyclin on ultrastructural features of human platelets in vitro.
    Weber G; Bianciardi G; Toti P; Sinzinger H
    Prostaglandins; 1981 Nov; 22(5):789-93. PubMed ID: 7036227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.